Ligand Pharmaceuticals Inc $51.24

down -0.51


22/8/2014 04:00 PM  |  NASDAQ : LGND  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get LGND Trend Analysis - it has underperformed the S&P 500 by 3%

Partner Headlines

  1. Stocks To Watch For August 12, 2014

    Benzinga
  2. Exclusive: Emmanuel Lemelson Talks Ligand Pharmaceuticals

    Benzinga
  3. Ligand Pharmaceuticals Reports Earnings; Lemelson Capital Adds To Short ...

    Benzinga
  4. Earnings Scheduled For August 4, 2014

    Benzinga
  5. Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! Falls On ...

    Benzinga
  6. Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

    Benzinga
  7. Benzinga's Volume Movers

    Benzinga
  8. Ligand to Present Positive Data from Phase 1 Study of Effect of SERN Lasofoxifene ...

    Benzinga
  9. Shares Of Ligand Follow Parabolic Curve Amid Responses Surrounding Promacta's ...

    Benzinga
  10. Ligand Pharmaceuticals - Severe competitive threat to key royalty program ...

    GuruFocus
  11. Indexes End With Small Gains; Tesla Drives Higher

    IBD
  12. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals ...

    Benzinga
  13. UPDATE: Ligand Pharma Announces Milestone from Sage Therapeutics for SAGE-547

    Benzinga
  14. Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled (Propylene ...

    Benzinga
  15. UPDATE: MLV & Co Reiterates on Ligand Pharmaceuticals Following Strong ...

    Benzinga
  16. Stocks End Near Session Highs; Ligand, Regeneron Jump

    IBD
  17. Ligand Pharmaceuticals Poised For Full-Year Profit

    IBD
  18. UPDATE: Cantor Fitzgerald Raises PT on Ligand Pharmaceuticals as Key Partnered ...

    Benzinga
  19. Ligand Pharmaceuticals Sees Q4 EPS $0.31-$0.32 vs $0.22-$0.24; Q4 Revenue ...

    Benzinga
  20. A Few Stocks Form Bases, But Have Flaws

    IBD
  21. Ligand Pharmaceuticals On Pace For Annual Profit

    IBD
  22. Ligand, NIC: Thinly Traded Stocks That Hold Promise

    IBD
  23. Ligand Partner GSK Receives Marketing Authorization from EC for Additional ...

    Benzinga
  24. Ligand Enters Global License Agreement with CURx Pharmaceuticals for Captisol-Enabled ...

    Benzinga
  25. Ligand Receives FDA Orphan Designation for Captisol-Enabled Topiramate ...

    Benzinga
  26. UPDATE: Cantor Fitzgerald Downgrades Ligand Pharmaceuticals to Hold, Lowers ...

    Benzinga
  27. FDA Accepts NDA for Pfizer, Ligand's Bazedoxifene/Conjugated Estrogens

    Benzinga
  28. Ligand Pharma Begins Pivotal Trial of Captisol-Enabled Propylene Glycol-Free ...

    Benzinga
  29. Ligand Pharmaceuticals, Inc. (LGND) CEO John L Higgins buys 2,000 Shares

    GuruFocus
  30. Benzinga's Volume Movers

    Benzinga
  31. Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication

    Benzinga
  32. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  33. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K/A)

    GuruFocus
  34. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  35. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  36. Ligand Pharma Announces Preclinical Data for LG-7501

    Benzinga
  37. Ligand to Receive $2 Million Milestone Payment from Merck; Re-Affirms FY ...

    Benzinga
  38. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  39. Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental ...

    Benzinga
  40. One Drugmaker Soars, 1 Falls

    IBD
  41. Onyx Up, Celgene Down On Cancer Drug News

    IBD
  42. ConAgra Foods, HONDA MOTOR CO. Among Stocks Up on High Volume Thursday

    FoxBusiness
  43. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus
  44. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  45. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  46. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  47. MLV & Co Affirms Ligand Pharmaceuticals Buy, $30 PT

    Benzinga
Trading Center